Abstract

Spherical agglomeration (SA) allows for intensifying a crystallization process through simultaneous particle size enlargement and process efficiency enhancement, without a compromise between bioavailability and processability of active pharmaceutical ingredients (APIs). Inefficient collision intensity may encounter during scale-up of an SA process, while mixing intensity and flow patterns do play critical roles especially in a batchwise stirred tank. In the present study, the scalability of an SA process by operating at all the same configurations of different scales, 0.5, 2, and 10 L, using a common one-layered impeller with four pitched blades was examined through the use of dimethyl fumarate as a model API. Insights into the guidelines for scaling up of the SA process are also given. Furthermore, the effects of impeller types, including the one-layered impeller, the two-layered impeller with four pitched blades, and the maxblend impeller, on the size, size distribution, and roundness of dimethyl fumarate agglomerates were investigated carefully.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call